3.連結財務諸表及び主な注記
(1)連結貸借対照表
|
|
|
|
|
|
|
|
|
|
|
|
(単位:千円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2021年12月31日)
|
当連結会計年度
(2022年12月31日)
|
|
資産の部
|
|
|
|
|
流動資産
|
|
|
|
|
|
現金及び預金
|
3,817,834
|
3,379,048
|
|
|
|
売掛金
|
1,243,839
|
182,426
|
|
|
|
商品及び製品
|
72,514
|
84,450
|
|
|
|
仕掛品
|
7,521
|
5,918
|
|
|
|
原材料及び貯蔵品
|
30,453
|
28,163
|
|
|
|
前渡金
|
720
|
285,909
|
|
|
|
その他
|
145,604
|
138,399
|
|
|
|
流動資産合計
|
5,318,487
|
4,104,316
|
|
|
固定資産
|
|
|
|
|
|
有形固定資産
|
|
|
|
|
|
|
建物及び構築物(純額)
|
23,634
|
29,421
|
|
|
|
|
機械装置及び運搬具(純額)
|
9
|
―
|
|
|
|
|
工具、器具及び備品(純額)
|
27,931
|
70,810
|
|
|
|
|
有形固定資産合計
|
51,574
|
100,231
|
|
|
|
無形固定資産
|
2,738
|
1,915
|
|
|
|
投資その他の資産
|
59,760
|
59,990
|
|
|
|
固定資産合計
|
114,073
|
162,137
|
|
|
資産合計
|
5,432,560
|
4,266,453
|
|
|
|
|
|
|
|
|
|
|
|
|
(単位:千円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2021年12月31日)
|
当連結会計年度
(2022年12月31日)
|
|
負債の部
|
|
|
|
|
流動負債
|
|
|
|
|
|
買掛金
|
2,294
|
1,962
|
|
|
|
1年内償還予定の社債
|
28,000
|
32,000
|
|
|
|
1年内返済予定の長期借入金
|
211,497
|
119,988
|
|
|
|
未払金
|
307,832
|
235,136
|
|
|
|
前受収益
|
177,707
|
―
|
|
|
|
未払法人税等
|
24,236
|
30,664
|
|
|
|
その他
|
23,087
|
16,654
|
|
|
|
流動負債合計
|
774,655
|
436,407
|
|
|
固定負債
|
|
|
|
|
|
社債
|
32,000
|
―
|
|
|
|
長期借入金
|
268,390
|
148,402
|
|
|
|
資産除去債務
|
37,434
|
38,040
|
|
|
|
その他
|
4,508
|
1,759
|
|
|
|
固定負債合計
|
342,332
|
188,201
|
|
|
負債合計
|
1,116,988
|
624,609
|
|
純資産の部
|
|
|
|
|
株主資本
|
|
|
|
|
|
資本金
|
1,056,953
|
1,382,246
|
|
|
|
資本剰余金
|
4,808,163
|
5,133,456
|
|
|
|
利益剰余金
|
△1,572,951
|
△2,922,490
|
|
|
|
自己株式
|
△222
|
△222
|
|
|
|
株主資本合計
|
4,291,942
|
3,592,988
|
|
|
その他の包括利益累計額
|
|
|
|
|
|
その他有価証券評価差額金
|
△630
|
△2,373
|
|
|
|
繰延ヘッジ損益
|
6,578
|
615
|
|
|
|
為替換算調整勘定
|
7,841
|
33,225
|
|
|
|
その他の包括利益累計額合計
|
13,789
|
31,467
|
|
|
新株予約権
|
9,840
|
17,388
|
|
|
純資産合計
|
4,315,572
|
3,641,844
|
|
負債純資産合計
|
5,432,560
|
4,266,453
|
E00987
45720
カルナバイオサイエンス株式会社
Carna Biosciences, Inc.
通期第1号様式 [日本基準](連結)
Japan GAAP
true
cte
cte
2022-01-01
2022-12-31
FY
2022-12-31
2021-01-01
2021-12-31
2021-12-31
1
false
false
false
45720
2022-01-01
2022-12-31
45720
2021-12-31
45720
2022-12-31
45720
2021-01-01
2021-12-31
45720
2021-12-31
jppfs_cor:CapitalStockMember
45720
2020-12-31
jppfs_cor:CapitalStockMember
45720
2021-12-31
jppfs_cor:CapitalSurplusMember
45720
2020-12-31
jppfs_cor:CapitalSurplusMember
45720
2021-12-31
jppfs_cor:RetainedEarningsMember
45720
2020-12-31
jppfs_cor:RetainedEarningsMember
45720
2021-12-31
jppfs_cor:TreasuryStockMember
45720
2020-12-31
jppfs_cor:TreasuryStockMember
45720
2020-12-31
jppfs_cor:ShareholdersEquityMember
45720
2021-12-31
jppfs_cor:ShareholdersEquityMember
45720
2021-12-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
45720
2020-12-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
45720
2021-12-31
jppfs_cor:DeferredGainsOrLossesOnHedgesMember
45720
2020-12-31
jppfs_cor:DeferredGainsOrLossesOnHedgesMember
45720
2020-12-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
45720
2021-12-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
45720
2021-12-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45720
2020-12-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45720
2021-12-31
jppfs_cor:SubscriptionRightsToSharesMember
45720
2020-12-31
jppfs_cor:SubscriptionRightsToSharesMember
45720
2020-12-31
45720
2022-01-01
2022-12-31
jppfs_cor:CapitalStockMember
45720
2021-01-01
2021-12-31
jppfs_cor:CapitalStockMember
45720
2021-01-01
2021-12-31
jppfs_cor:CapitalSurplusMember
45720
2022-01-01
2022-12-31
jppfs_cor:CapitalSurplusMember
45720
2021-01-01
2021-12-31
jppfs_cor:ShareholdersEquityMember
45720
2022-01-01
2022-12-31
jppfs_cor:ShareholdersEquityMember
45720
2022-01-01
2022-12-31
jppfs_cor:RetainedEarningsMember
45720
2021-01-01
2021-12-31
jppfs_cor:RetainedEarningsMember
45720
2022-01-01
2022-12-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
45720
2021-01-01
2021-12-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
45720
2022-01-01
2022-12-31
jppfs_cor:DeferredGainsOrLossesOnHedgesMember
45720
2021-01-01
2021-12-31
jppfs_cor:DeferredGainsOrLossesOnHedgesMember
45720
2022-01-01
2022-12-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
45720
2021-01-01
2021-12-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
45720
2021-01-01
2021-12-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45720
2022-01-01
2022-12-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45720
2021-01-01
2021-12-31
jppfs_cor:SubscriptionRightsToSharesMember
45720
2022-01-01
2022-12-31
jppfs_cor:SubscriptionRightsToSharesMember
45720
2021-01-01
2021-12-31
jppfs_cor:TreasuryStockMember
45720
2022-01-01
2022-12-31
jppfs_cor:TreasuryStockMember
45720
2022-12-31
jppfs_cor:CapitalStockMember
45720
2022-12-31
jppfs_cor:CapitalSurplusMember
45720
2022-12-31
jppfs_cor:RetainedEarningsMember
45720
2022-12-31
jppfs_cor:TreasuryStockMember
45720
2022-12-31
jppfs_cor:ShareholdersEquityMember
45720
2022-12-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
45720
2022-12-31
jppfs_cor:DeferredGainsOrLossesOnHedgesMember
45720
2022-12-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
45720
2022-12-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45720
2022-12-31
jppfs_cor:SubscriptionRightsToSharesMember
45720
2023-02-10
iso4217:JPY
xbrli:pure